RxDoctor Payments Data

Leon Kircik, MD

Dermatology · Lousiville, KYNPI 1760576599

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 50 manufacturers, the largest accounting for just 14.1%. Among dermatology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,477,881in general payments, 2019–2025

Across 3,116 payments — averaging $1437.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$631K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$555K
  • Lilly USA, LLC$490K
  • UCB, Inc.$359K
  • E.r. Squibb & Sons, L.L.C.$304K
  • LEO Pharma Inc.$277K
  • plus $1.9M from 44 others
$6,834,464in research payments, 2019–2025

Across 1,039 payments — averaging $6577.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Almirall LLC$937K
  • Bausch Health US, LLC$851K
  • Sanofi US Services Inc.$722K
  • Incyte Corporation$713K
  • LEO Pharma Inc.$702K
  • Eli Lilly$619K
  • plus $2.3M from 20 others

What the payments were for

  • Consulting fees$1,648,77537%
  • Speaking & faculty fees$2,178,33549%
  • Grants$156,1703%
  • Travel & lodging$418,1399%
  • Food & beverage$59,5211%
  • Education$16,9410%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sun Pharmaceutical Industries Inc.399$630,939
Ortho Dermatologics, A Division Of Bausch Health US, LLC311$554,541
Lilly USA, LLC439$490,298
UCB, Inc.341$358,512
E.r. Squibb & Sons, L.L.C.212$304,032
LEO Pharma Inc.142$276,591
Almirall LLC107$259,680
Novartis186$249,971
Pfizer177$199,624
Galderma Laboratories, L.p.93$182,187
Incyte Corporation171$169,122
Arcutis Biotherapeutics, Inc.92$112,224
EPI Health, LLC24$73,060
Dermavant Sciences, Inc.46$64,313
Eli Lilly46$51,360
Sanofi35$50,805
Mayne Pharma Commercial LLC6$45,380
Taro Pharmaceuticals USA, Inc.36$45,015
LEO Pharma AS18$42,121
Takeda Pharmaceuticals U.S.A., Inc.26$40,324
Amgen29$37,872
Organon23$33,263
Bristol Myers Squibb15$21,116
Sanofi-aventis U.S. LLC7$20,556
Novartis Pharma AG3$18,995
VYNE Pharmaceuticals Inc.10$17,237
Dermira, Inc.12$14,979
Mindera Corp3$14,650
AbbVie15$14,360
Regeneron Healthcare Solutions, Inc.8$13,594
Sanofi US Services Inc.3$8,784
Galderma Research & Development, LLC2$8,000
Biofrontera Inc.7$7,445
Boehringer Ingelheim14$6,813
Aclaris Therapeutics, Inc.7$6,422
Johnson & Johnson(2 entities)14$6,174
Regeneron8$5,387
Janssen Scientific Affairs, LLC9$5,373
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$4,650
Kowa Pharmaceuticals America, Inc.3$4,222
Botanix SB Inc1$2,200
Orapharma, A Division Of Bausch Health US, LLC1$2,000
LNHC, Inc1$1,500
Zerigo Health, Inc.1$1,000
Strata Skin Sciences, Inc.1$700
Glenmark Therapeutics Inc.3$307
Janssen Research & Development, LLC1$59
Bausch & Lomb, A Division Of Bausch Health US, LLC1$50
AstraZeneca1$37
Bausch Health US, LLC1$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,477,881 in reported general payments places this provider in the 95th percentile of 128 dermatology providers in Kentucky.

See all dermatology providers in Kentucky

Medicare billing

Part B allowed, 2024
$122,060
Medicare patients
47
Services billed
433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Triamcinolone Acetonide12$187

Paid to pharmacies, not to this prescriber.

Other dermatology in Lousiville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →